HPSE and metastatic neoplasm: Furthermore, metastatic tumors showed greater variability in their levels of transcription, HPSE mRNA values appearing reduced in 40 % of patients, at the same time as 20 % of patients showing overexpression, results which combined to produce the lack of a statistically significant trend (p = 0.13).